Health & Nutrition

bg
BioCryst is profitable. Now it wants to buy more rare disease drugs

BioCryst is profitable. Now it wants to buy more rare disease...

Rare disease drug development is getting a boost from new funding models and a growing...

bg
How Taylor Farms became integral to America's food supply system

How Taylor Farms became integral to America's food supply...

Taylor Farms and other suppliers have become larger and more integral to the U.S....

bg
The Corporate Playbook Behind Undermining Dietary Guidelines

The Corporate Playbook Behind Undermining Dietary Guidelines

International Life Sciences Institute, a nonprofit, is accused of being a front...

bg
The Burden of Weight Bias

The Burden of Weight Bias

Please note: This blog and its accompanying video discuss the important and troubling...

bg
Most Americans aren't anti-vaccine. They're uncertain — and that's a growing public health challenge

Most Americans aren't anti-vaccine. They're uncertain —...

The bigger issue at hand may be that many Americans fall into a large, uncertain...

bg
Weight Bias in Health Care

Weight Bias in Health Care

Please note: This blog and its accompanying video discuss the important and troubling...

bg
Hims & Hers CEO says FTC lawsuit misunderstands how the company works

Hims & Hers CEO says FTC lawsuit misunderstands how the...

Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the...

bg
Nuts, Meat, and the Flaw in Nutrition Studies

Nuts, Meat, and the Flaw in Nutrition Studies

Do people who eat nuts live longer simply because they replace protein from animals...

bg
The startup using AI to help rare disease families develop custom treatments

The startup using AI to help rare disease families develop...

Nome uses AI and drug-development expertise to help rare disease families turn genetic...

bg
Court rules companies can't import Gilead medications from overseas in blow to AFP health programs

Court rules companies can't import Gilead medications from...

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known...